Rosina Samadani, PhD -- Dr. Samadani is CEO of Oculogica. She is a serial entrepreneur who founded and led three startups in healthcare technology: Capella Advisors, a boutique management consulting firm to the pharmaceutical, medical device, and biotech industry as well as to hospital systems; Truth On Call, a market research firm utilizing a proprietary text and email based platform to get input from physicians to provide uber-rapid market feedback; and DocNews, which developed an app that helped physicians stay up to date on medical literature. Prior to her startup work, Dr. Samadani was with McKinsey & Company for 7 years, where she served pharmaceutical, biotech, medical device, physician services, and payer companies. She has worked on all aspects of strategy from clinical development to lifecycle management. She has her BS and MS from MIT in Mechanical Engineering, and her Ph.D. from Northwestern University in Biomedical Engineering. Dr. Samadani was a National Science Foundation Fellow and a Helen Bernstein Health Sciences and Technology Fellow.
Board of Directors
Uzma Samadani, MD, PhD -- Dr. Uzma Samadani is the founder of Oculogica and Rockswold Kaplan Endowed Chair for Traumatic Brain Injury at Hennepin County Medical Center and Associate Professor of Neurosurgery at the University of Minnesota. She serves on the American Association of Neurological Surgeons/Congress of Neurological Surgeons Executive Committee for Trauma and Critical Care and is Scientific Program Chair of the AANS/CNS National Neurotrauma Society Joint Meeting. Previously, Dr. Samadani was the Chief of Neurosurgery at the New York Harbor Heath Care System where she was awarded more than $1,000,000 in VA research funding to study brain injury and hemorrhage. She was also Co-Director of the Cohen Veteran Center for Post Traumatic Stress and Traumatic Brain Injury and an Assistant Professor of Neurosurgery at New York University School of Medicine with joint appointments in the Departments of Psychiatry and Physiology & Neuroscience. Dr. Samadani is a Phi Beta Kappa graduate of the University of Wisconsin Madison where she won the Academic Award for Excellence in science research, as one of the top two undergraduate researchers in the College of Letters and Sciences. She then completed a PhD and MD at the University of Illinois where she was awarded two fellowships including the Charlotte Webster Barnes, Helen T. Barnes and Broda O. Barnes Research Fellowship for Molecular Medicine. Upon completion of medical school, Dr. Samadani undertook internship and neurosurgery residency at the Hospital of the University of Pennsylvania. She served as the 2006 Van Wagenen foundation fellow. The Van Wagenen fellowship is one of the most prestigious in neurosurgery with more than one-third of former fellows subsequently becoming chairs of neurosurgical departments.
Bilal Khan, MBA -- Bilal Khan is currently Vice President and Chief Operating Officer of New World Medical, a medical device firm based in Rancho Cucamonga, California. New World Medical manufactures and markets its own products in over 90 countries. Their product, the Ahmed Glaucoma Valve (AGV), is a global leader in glaucoma valves and was recognized as the United States Commerce Department’s "Exporter of the Year” in 2002. Prior to joining New World Medical, he worked as an Actuary in Chicago, Los Angeles, and London, becoming a Fellow of the Society of Actuaries in 2008. Mr. Khan holds a Bachelor of Business Administration in Actuarial Science from the University of Wisconsin-Madison, and a Master of Business Administration in Management from The Wharton School of the University of Pennsylvania, where he graduated with honors.